Purpose: To assess the safety to the corneal endothelium of the irradiation delivered through a system developed for noninvasive postoperative power adjustments of the Light Adjustable Lens (LAL) (Calhoun Vision).
Setting: John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Methods: After anesthesia, 12 cats had a light beam of near ultraviolet light (365 nm), with an intensity of 250 mW/cm(2), applied to the central 6.0 mm of the right cornea for 120 seconds. The cats were killed 1 day, 1 week, and 1 and 3 months after light application (3 cats/time point). Their corneas were then removed and evaluated for evidence of morphological damage to the corneal endothelial cells by staining with trypan blue and alizarin red and quantification with a digital imaging program (EPCO system).
Results: The overall size and shape of the corneal endothelial cells were qualitatively similar in irradiated and nonirradiated eyes. Four corneas in the irradiated group and 3 corneas in the control group had small areas of cell damage (staining with trypan blue) within the central 6.0 mm. These areas were generally close to corneal folds. The differences in damaged areas between both groups at each time point, as well as the difference considering the overall results in both groups, were not significant (P>.05).
Conclusions: Irradiation of cat corneas with the therapeutic dose used to lock in the power of the LAL was not associated with damage to endothelial cells. Further studies are necessary to confirm the absence of damage at the ultrastructural level.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcrs.2007.01.024 | DOI Listing |
Int Ophthalmol
January 2025
Ophthalmology Department, Faculty of Medicine - Suez Canal University Hospitals, 4.5 Kilo - Ring Road, Ismailia, 41522, Egypt.
Purpose: To assess the effect of anterior chamber depth on corneal endothelium using specular microscopy following uneventful phacoemulsification among cataract patients with different axial lengths.
Methods: The study was conducted in a quasi-experimental design including 300 eyes of 300 patients with grade three age-related nuclear cataract distributed equally based on their axial length into three equal groups. All eyes had grade three nuclear cataract.
Cornea
January 2025
Department of Ophthalmology, Edith Wolfson Medical Center, Holon, Israel.
Purpose: To present 4 family members with posterior polymorphous corneal dystrophy (PPCD), nonkeratoconic steep corneas, and myopia caused by a previously unknown genetic alteration in the ZEB1 gene.
Methods: Ophthalmic examinations and corneal curvature analyses were performed for all patients. Whole-exome targeted gene panel sequencing was performed for 1 patient.
Cont Lens Anterior Eye
January 2025
Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Américo Vespucio 24, 41092 Seville, Spain.
Purpose: To evaluate the role of contact lenses (CLs) in visual rehabilitation following keratoplasty.
Methods: Four databases, including PubMed, Scopus, Web of Science, and Embase were systematically searched for studies published between January 2010 and July 2023. Visual outcomes, daily wearing duration, subjective comfort, rate and etiology of CL discontinuation, corneal endothelial cell density, central corneal thickness, and complications were extracted.
Cornea
January 2025
Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; and.
Purpose: Congenital hereditary endothelial dystrophy (CHED) impairs the sensitive phase of visual development. We examined results of Descemet stripping automated endothelial keratoplasty (DSAEK) for CHED regarding the critical period for amblyogenic factors.
Methods: Retrospective analysis of 11 eyes of 6 consecutive patients with CHED younger than 8 years treated with DSAEK and a PubMed-based literature search on management and optimal timing of the intervention.
J Control Release
January 2025
Department of Pharmaceutical Sciences, College of Pharmacy, Robertson Life Sciences Building, Oregon State University, Portland, OR 97201, USA; Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, OR 97239, USA; Department of Biomedical Engineering, Robertson Life Sciences Building, Oregon Health & Science University, Portland, OR 97201, USA. Electronic address:
Lipid nanoparticles (LNPs) have shown great potential in the field of gene therapy for retinal diseases. To expand on this application, we investigated LNP-mediated mRNA delivery to the anterior chamber of the eye via the intracameral (IC) route of administration. Here, we show that IC injections of LNPs facilitated protein expression and gene editing in the trabecular meshwork (TM).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!